Perbak Capital Partners LLP Elanco Animal Health Inc Transaction History
Perbak Capital Partners LLP
- $338 Billion
- Q2 2024
A detailed history of Perbak Capital Partners LLP transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Perbak Capital Partners LLP holds 332,250 shares of ELAN stock, worth $4.81 Million. This represents 1.42% of its overall portfolio holdings.
Number of Shares
332,250Holding current value
$4.81 Million% of portfolio
1.42%Shares
1 transactions
Others Institutions Holding ELAN
# of Institutions
447Shares Held
478MCall Options Held
3.1MPut Options Held
1.26M-
Dodge & Cox San Francisco, CA83.6MShares$1.21 Billion0.76% of portfolio
-
Primecap Management CO Pasadena, CA52.8MShares$765 Million0.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA49.4MShares$716 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD28.1MShares$407 Million0.05% of portfolio
-
Black Rock Inc. New York, NY23.3MShares$338 Million0.01% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $6.87B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...